• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫接种 LRP1 受体的 Gly-Cys 氨基酸序列可减少兔动脉粥样硬化。分子、免疫组织化学和核医学成像研究。

Immunization with the Gly-Cys amino acid sequence of the LRP1 receptor reduces atherosclerosis in rabbits. Molecular, immunohistochemical and nuclear imaging studies.

机构信息

Institute of Biomedical Research of Barcelona (IIBB). Spanish National Research Council (CSIC), Barcelona, Spain.

Lipids and Cardiovascular Pathology. Biomedical Research Institute Sant Pau (IIB Sant Pau), Hospital de la Santa Creu i Sant Pau. Barcelona. Spain.

出版信息

Theranostics. 2020 Feb 10;10(7):3263-3280. doi: 10.7150/thno.37305. eCollection 2020.

DOI:10.7150/thno.37305
PMID:32194867
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7053206/
Abstract

: The LRP1 (CR9) domain and, in particular, the sequence Gly-Cys (P3) plays a critical role in the binding and internalization of aggregated LDL (agLDL). We aimed to evaluate whether immunization with P3 reduces high-fat diet (HFD)-induced atherosclerosis. : Female New Zealand White (NZW) rabbits were immunized with a primary injection and four reminder doses (R1-R4) of IrP (irrelevant peptide) or P3 conjugated to the carrier. IrP and P3-immunized rabbits were randomly divided into a normal diet group and a HFD-fed group. Anti-P3 antibody levels were determined by ELISA. Lipoprotein profile, circulating and tissue lipids, and vascular pro-inflammatory mediators were determined using standardized methods while atherosclerosis was determined by confocal microscopy studies and non-invasive imaging (PET/CT and Doppler ultrasonography). Studies treating human macrophages (hMΦ) and coronary vascular smooth muscle cells (hcVSMC) with rabbit serums were performed to ascertain the potential impact of anti-P3 Abs on the functionality of these crucial cells. : P3 immunization specifically induced the production of anti-P3 antibodies (Abs) and did not alter the lipoprotein profile. HFD strongly induced cholesteryl ester (CE) accumulation in the aorta of both the control and IrP groups, and their serum dose-dependently raised the intracellular CE of hMΦ and hcVSMC, promoting TNFR1 and phospho-NF-kB (p65) overexpression. These HFD pro-inflammatory effects were dramatically decreased in the aorta of P3-immunized rabbits and in hMΦ and hcVSMC exposed to the P3 rabbit serums. Microscopy studies revealed that P3 immunization reduced the percentage of lipids, macrophages, and SMCs in the arterial intima, as well as the atherosclerotic extent and lesion area in the aorta. PET/CT and Doppler ultrasonography studies showed that the average standardized uptake value (SUV) of the aorta and the arterial resistance index (ARI) of the carotids were more upregulated by HFD in the control and IrP groups than the P3 group. : P3 immunization counteracts HFD-induced fatty streak formation in rabbits. The specific blockade of the LRP1 (CR9) domain with Anti-P3 Abs dramatically reduces HFD-induced intracellular CE loading and harmful coupling to pro-inflammatory signaling in the vasculature.

摘要

LRP1(CR9)结构域,特别是 Gly-Cys(P3)序列,在聚集 LDL(agLDL)的结合和内化中起着关键作用。我们旨在评估免疫接种 P3 是否可以减少高脂肪饮食(HFD)诱导的动脉粥样硬化。

雌性新西兰白兔(NZW)用初级注射和四个提醒剂量(R1-R4)的 IrP(无关肽)或 P3 与载体结合进行免疫接种。IrP 和 P3 免疫接种的兔子被随机分为正常饮食组和 HFD 喂养组。通过 ELISA 测定抗 P3 抗体水平。使用标准方法测定脂蛋白谱、循环和组织脂质以及血管促炎介质,通过共聚焦显微镜研究和非侵入性成像(PET/CT 和多普勒超声)测定动脉粥样硬化。用兔血清处理人巨噬细胞(hMΦ)和冠状动脉平滑肌细胞(hcVSMC)的研究,以确定抗 P3 Abs 对这些关键细胞功能的潜在影响。

P3 免疫接种特异性诱导抗 P3 抗体(Abs)的产生,并且不改变脂蛋白谱。HFD 强烈诱导对照组和 IrP 组主动脉中胆固醇酯(CE)的积累,其血清剂量依赖性地增加 hMΦ 和 hcVSMC 中的细胞内 CE,促进 TNFR1 和磷酸化 NF-kB(p65)的过度表达。在 P3 免疫接种的兔子的主动脉中和暴露于 P3 兔血清的 hMΦ 和 hcVSMC 中,这些 HFD 促炎作用明显降低。显微镜研究表明,P3 免疫接种降低了动脉内膜中的脂质、巨噬细胞和 SMC 的百分比,以及主动脉中的动脉粥样硬化程度和病变面积。PET/CT 和多普勒超声研究表明,在对照组和 IrP 组中,HFD 对主动脉的平均标准化摄取值(SUV)和颈动脉的动脉阻力指数(ARI)的上调作用大于 P3 组。

P3 免疫接种可拮抗 HFD 诱导的兔脂肪条纹形成。LRP1(CR9)结构域的特异性阻断用抗 P3 Abs 可显著减少 HFD 诱导的细胞内 CE 负荷,并减少血管中促炎信号的有害偶联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89a0/7053206/15be0230877b/thnov10p3263g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89a0/7053206/3f3cf6c44516/thnov10p3263g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89a0/7053206/7aab71516e28/thnov10p3263g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89a0/7053206/ae9ce0b2754d/thnov10p3263g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89a0/7053206/ba58af0ab7a6/thnov10p3263g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89a0/7053206/187eb1a23109/thnov10p3263g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89a0/7053206/093f545f2cf7/thnov10p3263g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89a0/7053206/f771b8e77100/thnov10p3263g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89a0/7053206/1dcbefecfa2d/thnov10p3263g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89a0/7053206/9f37d9aebd2b/thnov10p3263g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89a0/7053206/b37388a6b64d/thnov10p3263g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89a0/7053206/15be0230877b/thnov10p3263g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89a0/7053206/3f3cf6c44516/thnov10p3263g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89a0/7053206/7aab71516e28/thnov10p3263g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89a0/7053206/ae9ce0b2754d/thnov10p3263g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89a0/7053206/ba58af0ab7a6/thnov10p3263g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89a0/7053206/187eb1a23109/thnov10p3263g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89a0/7053206/093f545f2cf7/thnov10p3263g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89a0/7053206/f771b8e77100/thnov10p3263g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89a0/7053206/1dcbefecfa2d/thnov10p3263g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89a0/7053206/9f37d9aebd2b/thnov10p3263g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89a0/7053206/b37388a6b64d/thnov10p3263g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89a0/7053206/15be0230877b/thnov10p3263g011.jpg

相似文献

1
Immunization with the Gly-Cys amino acid sequence of the LRP1 receptor reduces atherosclerosis in rabbits. Molecular, immunohistochemical and nuclear imaging studies.免疫接种 LRP1 受体的 Gly-Cys 氨基酸序列可减少兔动脉粥样硬化。分子、免疫组织化学和核医学成像研究。
Theranostics. 2020 Feb 10;10(7):3263-3280. doi: 10.7150/thno.37305. eCollection 2020.
2
K Domain CR9 of Low Density Lipoprotein (LDL) Receptor-related Protein 1 (LRP1) Is Critical for Aggregated LDL-induced Foam Cell Formation from Human Vascular Smooth Muscle Cells.低密度脂蛋白(LDL)受体相关蛋白1(LRP1)的K结构域CR9对于聚集的LDL诱导人血管平滑肌细胞形成泡沫细胞至关重要。
J Biol Chem. 2015 Jun 12;290(24):14852-65. doi: 10.1074/jbc.M115.638361. Epub 2015 Apr 27.
3
Targeting cholesteryl ester accumulation in the heart improves cardiac insulin response.靶向心脏中的胆固醇酯积累可改善心脏胰岛素反应。
Biomed Pharmacother. 2022 Aug;152:113270. doi: 10.1016/j.biopha.2022.113270. Epub 2022 Jun 13.
4
Inhibitory Effects of LRP1-Based Immunotherapy on Cardiac Extracellular Matrix Biophysical Alterations Induced by Hypercholesterolemia.基于 LRP1 的免疫疗法对高胆固醇血症引起的心脏细胞外基质生物物理改变的抑制作用。
J Med Chem. 2023 May 11;66(9):6251-6262. doi: 10.1021/acs.jmedchem.2c02103. Epub 2023 Apr 28.
5
Sterol regulatory element binding proteins downregulate LDL receptor-related protein (LRP1) expression and LRP1-mediated aggregated LDL uptake by human macrophages.固醇调节元件结合蛋白下调人巨噬细胞中低密度脂蛋白受体相关蛋白(LRP1)的表达以及LRP1介导的聚集型低密度脂蛋白摄取。
Cardiovasc Res. 2007 Jun 1;74(3):526-36. doi: 10.1016/j.cardiores.2007.02.020. Epub 2007 Feb 21.
6
Effects of atorvastatin and diet interventions on atherosclerotic plaque inflammation and [F]FDG uptake in LdlrApob mice.阿托伐他汀和饮食干预对 LDLRAPOB 小鼠动脉粥样硬化斑块炎症和 [F]FDG 摄取的影响。
Atherosclerosis. 2017 Aug;263:369-376. doi: 10.1016/j.atherosclerosis.2017.04.004. Epub 2017 Apr 11.
7
Cholesteryl esters of aggregated LDL are internalized by selective uptake in human vascular smooth muscle cells.聚集的低密度脂蛋白的胆固醇酯通过人血管平滑肌细胞的选择性摄取而被内化。
Arterioscler Thromb Vasc Biol. 2006 Jan;26(1):117-23. doi: 10.1161/01.ATV.0000193618.32611.8b. Epub 2005 Oct 27.
8
Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.氟-18 氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描检测斑块炎症对兔模型动脉粥样硬化主动脉的成像。
Chin Med J (Engl). 2011 Mar;124(6):911-7.
9
Aggregated low-density lipoprotein induces LRP1 stabilization through E3 ubiquitin ligase CHFR downregulation in human vascular smooth muscle cells.聚集的低密度脂蛋白通过下调人血管平滑肌细胞中的 E3 泛素连接酶 CHFR 诱导 LRP1 的稳定。
Arterioscler Thromb Vasc Biol. 2013 Feb;33(2):369-77. doi: 10.1161/ATVBAHA.112.300748. Epub 2012 Dec 13.
10
LDL receptor-related protein mediates uptake of aggregated LDL in human vascular smooth muscle cells.低密度脂蛋白受体相关蛋白介导人血管平滑肌细胞中聚集型低密度脂蛋白的摄取。
Arterioscler Thromb Vasc Biol. 2000 Jun;20(6):1572-9. doi: 10.1161/01.atv.20.6.1572.

引用本文的文献

1
Mitigating atherosclerosis: Integrating vaccines with gene targets.减轻动脉粥样硬化:将疫苗与基因靶点相结合。
Am Heart J Plus. 2025 Aug 6;57:100588. doi: 10.1016/j.ahjo.2025.100588. eCollection 2025 Sep.
2
LRP1 immunotherapy enhances cardiomyocyte respiration by restricting cholesteryl ester accumulation in mitochondria.低密度脂蛋白受体相关蛋白1(LRP1)免疫疗法通过限制线粒体中胆固醇酯的积累来增强心肌细胞呼吸。
J Lipid Res. 2025 Mar 22;66(5):100783. doi: 10.1016/j.jlr.2025.100783.
3
Mechanisms modulating foam cell formation in the arterial intima: exploring new therapeutic opportunities in atherosclerosis.

本文引用的文献

1
Low Density Lipoprotein Receptor-Related Protein-1 in Cardiac Inflammation and Infarct Healing.低密度脂蛋白受体相关蛋白-1在心脏炎症和梗死愈合中的作用
Front Cardiovasc Med. 2019 Apr 26;6:51. doi: 10.3389/fcvm.2019.00051. eCollection 2019.
2
Major vault protein suppresses obesity and atherosclerosis through inhibiting IKK-NF-κB signaling mediated inflammation.主要穹窿蛋白通过抑制 IKK-NF-κB 信号转导介导的炎症来抑制肥胖和动脉粥样硬化。
Nat Commun. 2019 Apr 17;10(1):1801. doi: 10.1038/s41467-019-09588-x.
3
NFkappaB is a Key Player in the Crosstalk between Inflammation and Cardiovascular Diseases.
调节动脉内膜中泡沫细胞形成的机制:探索动脉粥样硬化的新治疗机会。
Front Cardiovasc Med. 2024 Jun 17;11:1381520. doi: 10.3389/fcvm.2024.1381520. eCollection 2024.
4
Genetic heterogeneity in cardiovascular disease across ancestries: Insights for mechanisms and therapeutic intervention.不同血统心血管疾病的遗传异质性:对发病机制和治疗干预的启示
Camb Prism Precis Med. 2023 Jan 10;1:e8. doi: 10.1017/pcm.2022.13. eCollection 2023.
5
Nanomedicine for Diagnosis and Treatment of Atherosclerosis.纳米医学用于动脉粥样硬化的诊断和治疗。
Adv Sci (Weinh). 2023 Dec;10(36):e2304294. doi: 10.1002/advs.202304294. Epub 2023 Oct 28.
6
Increased sLRP1 and decreased atrial natriuretic peptide plasma levels in newly diagnosed T2DM patients are normalized after optimization of glycemic control.新诊断的 2 型糖尿病患者中,sLRP1 水平升高,心钠肽血浆水平降低,血糖控制优化后恢复正常。
Front Endocrinol (Lausanne). 2023 Aug 10;14:1236487. doi: 10.3389/fendo.2023.1236487. eCollection 2023.
7
Inhibitory Effects of LRP1-Based Immunotherapy on Cardiac Extracellular Matrix Biophysical Alterations Induced by Hypercholesterolemia.基于 LRP1 的免疫疗法对高胆固醇血症引起的心脏细胞外基质生物物理改变的抑制作用。
J Med Chem. 2023 May 11;66(9):6251-6262. doi: 10.1021/acs.jmedchem.2c02103. Epub 2023 Apr 28.
8
Soluble low-density lipoprotein receptor-related protein 1 as a surrogate marker of carotid plaque inflammation assessed by F-FDG PET in patients with a recent ischemic stroke.可溶性低密度脂蛋白受体相关蛋白 1 作为近期缺血性脑卒中患者颈动脉斑块炎症的替代标志物,通过 F-FDG PET 评估。
J Transl Med. 2023 Feb 19;21(1):131. doi: 10.1186/s12967-022-03867-w.
9
Multitarget Activities of Müller Glial Cells and Low-Density Lipoprotein Receptor-Related Protein 1 in Proliferative Retinopathies.Müller 胶质细胞和低密度脂蛋白受体相关蛋白 1 在增殖性视网膜病变中的多靶点活性。
ASN Neuro. 2022 Jan-Dec;14:17590914221136365. doi: 10.1177/17590914221136365.
10
Decreased low-density lipoprotein receptor-related protein 1 expression in pro-inflammatory monocytes is associated with subclinical atherosclerosis.促炎单核细胞中低密度脂蛋白受体相关蛋白1表达降低与亚临床动脉粥样硬化相关。
Front Cardiovasc Med. 2022 Jul 26;9:949778. doi: 10.3389/fcvm.2022.949778. eCollection 2022.
NFkappaB 是炎症与心血管疾病相互作用的关键参与者。
Int J Mol Sci. 2019 Mar 30;20(7):1599. doi: 10.3390/ijms20071599.
4
multiplex molecular imaging of vascular inflammation using surface-enhanced Raman spectroscopy.利用表面增强拉曼光谱对血管炎症进行多重分子成像。
Theranostics. 2018 Nov 29;8(22):6195-6209. doi: 10.7150/thno.28665. eCollection 2018.
5
Low-Density Lipoprotein Receptor-Related Protein-1 Is a Therapeutic Target in Acute Myocardial Infarction.低密度脂蛋白受体相关蛋白-1是急性心肌梗死的治疗靶点。
JACC Basic Transl Sci. 2017 Oct 30;2(5):561-574. doi: 10.1016/j.jacbts.2017.05.007. eCollection 2017 Oct.
6
Precise theranostic nanomedicines for inhibiting vulnerable atherosclerotic plaque progression through regulation of vascular smooth muscle cell phenotype switching.通过调控血管平滑肌细胞表型转换抑制易损性动脉粥样硬化斑块进展的精准治疗性纳米药物。
Theranostics. 2018 Jun 12;8(13):3693-3706. doi: 10.7150/thno.24364. eCollection 2018.
7
LRP1 integrates murine macrophage cholesterol homeostasis and inflammatory responses in atherosclerosis.LRP1 整合了动脉粥样硬化中鼠巨噬细胞胆固醇稳态和炎症反应。
Elife. 2017 Nov 16;6:e29292. doi: 10.7554/eLife.29292.
8
Endothelial LRP1 regulates metabolic responses by acting as a co-activator of PPARγ.内皮细胞 LRP1 通过作为 PPARγ 的共激活剂来调节代谢反应。
Nat Commun. 2017 Apr 10;8:14960. doi: 10.1038/ncomms14960.
9
Macrophage Foam Cell-Derived Extracellular Vesicles Promote Vascular Smooth Muscle Cell Migration and Adhesion.巨噬细胞泡沫细胞衍生的细胞外囊泡促进血管平滑肌细胞迁移和黏附。
J Am Heart Assoc. 2016 Oct 17;5(10):e004099. doi: 10.1161/JAHA.116.004099.
10
Convergent Signaling Pathways Controlled by LRP1 (Receptor-related Protein 1) Cytoplasmic and Extracellular Domains Limit Cellular Cholesterol Accumulation.由低密度脂蛋白受体相关蛋白1(LRP1)的胞质和胞外结构域控制的趋同信号通路限制细胞胆固醇积累。
J Biol Chem. 2016 Mar 4;291(10):5116-27. doi: 10.1074/jbc.M116.714485. Epub 2016 Jan 19.